BPC-157 + TB-500 Combination

• May support recovery and comfort after strain or activity
• May support joint mobility and flexibility
• May support normal tissue maintenance
• May help reduce soreness to support overall activity levels

‍

• Cycle length: Typically 4 to 12 weeks depending on recovery goals, with rest periods between cycles
• Dosing: Individualized by your provider, usually by subcutaneous injection near the area of focus or systemically
• Stacking: Can be combined with MOTS-c for added energy and recovery support or NAD+ for cellular support

‍

• Athletes and active adults recovering from injury or strain
• Individuals with chronic joint or tendon concerns
• Patients in post-surgical recovery who want to support their recovery
• Those seeking to support mobility, reduce soreness, and build resilience

‍

• Some people notice improved recovery, reduced soreness, and better mobility within weeks
• Results typically build over several cycles
• Works well alongside physical therapy, exercise, and healthy nutrition
• Individual responses vary depending on health status and adherence to the plan

‍

These statements have not been evaluated by the Food and Drug Administration (FDA). Compounded peptide therapies are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. They are prepared by appropriately licensed U.S. compounding pharmacies pursuant to a valid, patient-specific prescription when determined medically appropriate by the treating physician. Treatment is individualized following a physician evaluation, and individual results vary.